These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 21692686)
1. The value of N-terminal proB-type natriuretic peptide for early identification of myocardial infarction in patients with high-risk non-ST-elevation acute coronary syndromes. Riezebos RK; Laarman GJ; Tijssen JGP; Verheugt FWA Clin Chem Lab Med; 2011 Aug; 49(8):1359-1365. PubMed ID: 21692686 [TBL] [Abstract][Full Text] [Related]
2. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Ogawa A; Seino Y; Yamashita T; Ogata K; Takano T Circ J; 2006 Nov; 70(11):1372-8. PubMed ID: 17062956 [TBL] [Abstract][Full Text] [Related]
3. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657 [TBL] [Abstract][Full Text] [Related]
4. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy. Fröhlich GM; Schoch B; Schmid F; Keller P; Sudano I; Lüscher TF; Noll G; Ruschitzka F; Enseleit F Int J Cardiol; 2012 Feb; 154(3):328-32. PubMed ID: 22044675 [TBL] [Abstract][Full Text] [Related]
5. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B; Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228 [TBL] [Abstract][Full Text] [Related]
6. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes. Zdravkovic V; Mladenovic V; Colic M; Bankovic D; Lazic Z; Petrovic M; Simic I; Knezevic S; Pantovic S; Djukic A; Zdravkovic N Kardiol Pol; 2013; 71(5):472-9. PubMed ID: 23788087 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores. Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547 [TBL] [Abstract][Full Text] [Related]
8. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction. Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK; Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388 [TBL] [Abstract][Full Text] [Related]
10. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes. Manenti ER; Bodanese LC; Camey SA; Polanczyk CA Clin Cardiol; 2006 Sep; 29(9):405-10. PubMed ID: 17007172 [TBL] [Abstract][Full Text] [Related]
12. NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome. Castro LR; Alencar MC; Barbosa MM; Nunes Mdo C; Cardoso JR; Ribeiro AL Arq Bras Cardiol; 2011 Dec; 97(6):456-61. PubMed ID: 22030563 [TBL] [Abstract][Full Text] [Related]
13. Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes. De Servi S; Mariani G; Piatti L; Leoncini M; Rubartelli P; Pitì A; Curello S; Galdangelo F; Vandoni P; Rossetti E; Mariani M; Boschetti E; Re G; Loznicker M J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):42-7. PubMed ID: 24492354 [TBL] [Abstract][Full Text] [Related]
15. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study. He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836 [TBL] [Abstract][Full Text] [Related]
16. Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS. Farhan S; Clare RM; Jarai R; Giugliano RP; Lokhnygina Y; Harrington RA; Kristin Newby L; Huber K Int J Cardiol; 2017 Apr; 232():264-270. PubMed ID: 28089149 [TBL] [Abstract][Full Text] [Related]
17. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP. Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165 [TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. Jernberg T; Lindahl B; Siegbahn A; Andren B; Frostfeldt G; Lagerqvist B; Stridsberg M; Venge P; Wallentin L J Am Coll Cardiol; 2003 Dec; 42(11):1909-16. PubMed ID: 14662251 [TBL] [Abstract][Full Text] [Related]
19. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis. Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908 [TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]